Niti to review concerns over pharma quality

Niti Aayog is addressing growing quality concerns in India's pharmaceutical industry by convening industry experts for discussions. The aim is to analyze the current state, understand challenges, and improve the quality of Indian pharmaceutical products to meet global standards. A meeting chaired by VK Paul will propose recommendations to ensure alignment with international regulations and patient safety.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/GmwUWSu
via IFTTT